BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lah JJ, Cui W, Hu KQ. Effects and mechanisms of silibinin on human hepatoma cell lines. World J Gastroenterol 2007; 13(40): 5299-5305 [PMID: 17879397 DOI: 10.3748/wjg.v13.i40.5299] [Cited by in CrossRef: 65] [Cited by in F6Publishing: 59] [Article Influence: 4.3] [Reference Citation Analysis]
Number Citing Articles
1 Sekar P, Ravitchandirane R, Khanam S, Muniraj N, Cassinadane AV. Novel molecules as the emerging trends in cancer treatment: an update. Med Oncol 2022;39:20. [PMID: 34982273 DOI: 10.1007/s12032-021-01615-6] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Yassin NYS, AbouZid SF, El-Kalaawy AM, Ali TM, Almehmadi MM, Ahmed OM. Silybum marianum total extract, silymarin and silibinin abate hepatocarcinogenesis and hepatocellular carcinoma growth via modulation of the HGF/c-Met, Wnt/β-catenin, and PI3K/Akt/mTOR signaling pathways. Biomed Pharmacother 2021;145:112409. [PMID: 34781148 DOI: 10.1016/j.biopha.2021.112409] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
3 Baby J, Devan AR, Kumar AR, Gorantla JN, Nair B, Aishwarya TS, Nath LR. Cogent role of flavonoids as key orchestrators of chemoprevention of hepatocellular carcinoma: A review. J Food Biochem 2021;45:e13761. [PMID: 34028054 DOI: 10.1111/jfbc.13761] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
4 Betsou A, Lambropoulou M, Georgakopoulou AE, Kostomitsopoulos N, Konstandi O, Anagnostopoulos K, Tsalikidis C, Simopoulos CE, Valsami G, Tsaroucha AK. The hepatoprotective effect of silibinin after hepatic ischemia/reperfusion in a rat model is confirmed by immunohistochemistry and qRT-PCR. J Pharm Pharmacol 2021:rgab062. [PMID: 33847359 DOI: 10.1093/jpp/rgab062] [Reference Citation Analysis]
5 Ghalehkhondabi V, Soleymani M, Fazlali A. Folate-targeted nanomicelles containing silibinin as an active drug delivery system for liver cancer therapy. Journal of Drug Delivery Science and Technology 2021;61:102157. [DOI: 10.1016/j.jddst.2020.102157] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 8.0] [Reference Citation Analysis]
6 Mashhadi Akbar Boojar M, Mashhadi Akbar Boojar M, Golmohammad S. Overview of Silibinin anti-tumor effects. Journal of Herbal Medicine 2020;23:100375. [DOI: 10.1016/j.hermed.2020.100375] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
7 Elsayed SA, Harrypersad S, Sahyon HA, El-Magd MA, Walsby CJ. Ruthenium(II)/(III) DMSO-Based Complexes of 2-Aminophenyl Benzimidazole with In Vitro and In Vivo Anticancer Activity. Molecules 2020;25:E4284. [PMID: 32962014 DOI: 10.3390/molecules25184284] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Abid F, Saleem M, Yasir S, Arshad S, Qureshi S, Bajwa MA, Ashiq S, Tanveer S, Qayyum M, Ashiq K. CANCER EPIGENETICS AND THE ROLE OF DIETARY ELEMENTS. GJMS 2020;17:96-104. [DOI: 10.46903/gjms/17.03.2070] [Reference Citation Analysis]
9 Laszló I, Laszló MR, Toma V, Baldea I, Olteanu D, David L, Moldovan B, Ion RM, Moldovan R, Filip GA, Kacso G, Cainap C, Clichici S, Muresan A. The in vivo modulatory effects of Cornus mas extract on photodynamic therapy in experimental tumors. Photodiagnosis and Photodynamic Therapy 2020;30:101656. [DOI: 10.1016/j.pdpdt.2020.101656] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 He J, Chen Z, Gu Y, Li Y, Wang R, Gao Y, Feng W, Wang T. Hydrophilic co-assemblies of two hydrophobic biomolecules improving the bioavailability of silybin. Food Funct 2020;11:10828-38. [DOI: 10.1039/d0fo01882a] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Jahanafrooz Z, Motamed N, Rinner B, Mokhtarzadeh A, Baradaran B. Silibinin to improve cancer therapeutic, as an apoptotic inducer, autophagy modulator, cell cycle inhibitor, and microRNAs regulator. Life Sci 2018;213:236-47. [PMID: 30308184 DOI: 10.1016/j.lfs.2018.10.009] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 7.5] [Reference Citation Analysis]
12 El-far M, Salah N, Essam A, Abd El-azim AO, El-sherbiny IM. Silymarin nanoformulation as potential anticancer agent in experimental Ehrlich ascites carcinoma-bearing animals. Nanomedicine 2018;13:1865-58. [DOI: 10.2217/nnm-2017-0394] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
13 Zhang X, Liu J, Zhang P, Dai L, Wu Z, Wang L, Cao M, Jiang J. Silibinin induces G1 arrest, apoptosis and JNK/SAPK upregulation in SW1990 human pancreatic cancer cells. Oncol Lett 2018;15:9868-76. [PMID: 29805688 DOI: 10.3892/ol.2018.8541] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
14 Li BX, Wang HB, Qiu MZ, Luo QY, Yi HJ, Yan XL, Pan WT, Yuan LP, Zhang YX, Xu JH, Zhang L, Yang DJ. Novel smac mimetic APG-1387 elicits ovarian cancer cell killing through TNF-alpha, Ripoptosome and autophagy mediated cell death pathway. J Exp Clin Cancer Res 2018;37:53. [PMID: 29530056 DOI: 10.1186/s13046-018-0703-9] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
15 Hupa KL, Jaeckel E, Manns MP. Silymarin for Treatment of Nonalcoholic Steatohepatitis-A New Kid on the Block? Clin Gastroenterol Hepatol 2017;15:1863-5. [PMID: 28804034 DOI: 10.1016/j.cgh.2017.08.005] [Reference Citation Analysis]
16 Dionisie V, Clichici S, Ion RM, Danila OO, Moldovan R, Decea N, Gheban D, Olteanu FC, Filip GA. In vivo silymarin’s antioxidant and anti-apoptotic effects on photodynamic therapy’s responsiveness. J Porphyrins Phthalocyanines 2017;21:189-97. [DOI: 10.1142/s1088424617500304] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
17 Federico A, Dallio M, Loguercio C. Silymarin/Silybin and Chronic Liver Disease: A Marriage of Many Years. Molecules 2017;22:E191. [PMID: 28125040 DOI: 10.3390/molecules22020191] [Cited by in Crossref: 132] [Cited by in F6Publishing: 109] [Article Influence: 26.4] [Reference Citation Analysis]
18 Anestopoulos I, Sfakianos AP, Franco R, Chlichlia K, Panayiotidis MI, Kroll DJ, Pappa A. A Novel Role of Silibinin as a Putative Epigenetic Modulator in Human Prostate Carcinoma. Molecules 2016;22:E62. [PMID: 28042859 DOI: 10.3390/molecules22010062] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
19 Polachi N, Bai G, Li T, Chu Y, Wang X, Li S, Gu N, Wu J, Li W, Zhang Y, Zhou S, Sun H, Liu C. Modulatory effects of silibinin in various cell signaling pathways against liver disorders and cancer – A comprehensive review. European Journal of Medicinal Chemistry 2016;123:577-95. [DOI: 10.1016/j.ejmech.2016.07.070] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 5.7] [Reference Citation Analysis]
20 Zhu XX, Ding YH, Wu Y, Qian LY, Zou H, He Q. Silibinin: a potential old drug for cancer therapy. Expert Rev Clin Pharmacol. 2016; 18: 1-8 Epub ahead of print. [PMID: 27362364 DOI: 10.1080/17512433.2016.1208563] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 3.5] [Reference Citation Analysis]
21 Fang LH, Liu SL, Wang RP, Hu SY, Ju WZ, Li CY. Tounong Powder () extracts induce G1 cell cycle arrest and apoptosis in LoVo cells. Chin J Integr Med 2016. [PMID: 27358203 DOI: 10.1007/s11655-016-2597-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
22 Beydogan AB, Bolkent S. The effects of silibin administration for different time periods on mouse liver with Ehrlich ascites carcinoma. Pharmacol Rep 2016;68:543-9. [PMID: 26891241 DOI: 10.1016/j.pharep.2015.12.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
23 Liao CY, Lee CC, Tsai CC, Hsueh CW, Wang CC, Chen IH, Tsai MK, Liu MY, Hsieh AT, Su KJ. Novel Investigations of Flavonoids as Chemopreventive Agents for Hepatocellular Carcinoma. Biomed Res Int. 2015;2015:840542. [PMID: 26858957 DOI: 10.1155/2015/840542] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 4.0] [Reference Citation Analysis]
24 Wang X, Wang N, Cheung F, Lao L, Li C, Feng Y. Chinese medicines for prevention and treatment of human hepatocellular carcinoma: current progress on pharmacological actions and mechanisms. J Integr Med. 2015;13:142-164. [PMID: 26006028 DOI: 10.1016/s2095-4964(15)60171-6] [Cited by in Crossref: 61] [Cited by in F6Publishing: 42] [Article Influence: 8.7] [Reference Citation Analysis]
25 Busch C, Burkard M, Leischner C, Lauer UM, Frank J, Venturelli S. Epigenetic activities of flavonoids in the prevention and treatment of cancer. Clin Epigenetics 2015;7:64. [PMID: 26161152 DOI: 10.1186/s13148-015-0095-z] [Cited by in Crossref: 102] [Cited by in F6Publishing: 82] [Article Influence: 14.6] [Reference Citation Analysis]
26 Mastron JK, Siveen KS, Sethi G, Bishayee A. Silymarin and hepatocellular carcinoma: a systematic, comprehensive, and critical review. Anti-Cancer Drugs 2015;26:475-86. [DOI: 10.1097/cad.0000000000000211] [Cited by in Crossref: 49] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
27 Liou W, Chen L, Niu H, Yang T, Cheng J, Lin K. Herbal product silibinin-induced programmed cell death is enhanced by metformin in cervical cancer cells at the dose without influence on nonmalignant cells. J Appl Biomed 2015;13:113-21. [DOI: 10.1016/j.jab.2014.11.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
28 Tsai CC, Chuang TW, Chen LJ, Niu HS, Chung KM, Cheng JT, Lin KC. Increase in apoptosis by combination of metformin with silibinin in human colorectal cancer cells. World J Gastroenterol 2015; 21(14): 4169-4177 [PMID: 25892866 DOI: 10.3748/wjg.v21.i14.4169] [Cited by in CrossRef: 30] [Cited by in F6Publishing: 24] [Article Influence: 4.3] [Reference Citation Analysis]
29 Gu HR, Park SC, Choi SJ, Lee JC, Kim YC, Han CJ, Kim J, Yang KY, Kim YJ, Noh GY, No SH, Jeong JH. Combined treatment with silibinin and either sorafenib or gefitinib enhances their growth-inhibiting effects in hepatocellular carcinoma cells. Clin Mol Hepatol 2015;21:49-59. [PMID: 25834802 DOI: 10.3350/cmh.2015.21.1.49] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
30 Anestopoulos I, Voulgaridou GP, Georgakilas AG, Franco R, Pappa A, Panayiotidis MI. Epigenetic therapy as a novel approach in hepatocellular carcinoma. Pharmacol Ther. 2015;145:103-119. [PMID: 25205159 DOI: 10.1016/j.pharmthera.2014.09.005] [Cited by in Crossref: 40] [Cited by in F6Publishing: 37] [Article Influence: 5.0] [Reference Citation Analysis]
31 Oufi HG, Al-shawi NN. The effects of different doses of silibinin in combination with methotrexate on testicular tissue of mice. European Journal of Pharmacology 2014;730:36-40. [DOI: 10.1016/j.ejphar.2014.02.010] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
32 Yurtcu E, İşeri Ö, Sahin F. Genotoxic and cytotoxic effects of doxorubicin and silymarin on human hepatocellular carcinoma cells. Hum Exp Toxicol 2014;33:1269-76. [PMID: 24677352 DOI: 10.1177/0960327114529453] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
33 Cheng KC, Asakawa A, Li YX, Chung HH, Amitani H, Ueki T, Cheng JT, Inui A. Silymarin induces insulin resistance through an increase of phosphatase and tensin homolog in Wistar rats. PLoS One 2014;9:e84550. [PMID: 24404172 DOI: 10.1371/journal.pone.0084550] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
34 Ghasemi R, Ghaffari SH, Momeny M, Pirouzpanah S, Yousefi M, Malehmir M, Alimoghaddam K, Ghavamzadeh A. Multitargeting and antimetastatic potentials of silibinin in human HepG-2 and PLC/PRF/5 hepatoma cells. Nutr Cancer. 2013;65:590-599. [PMID: 23659451 DOI: 10.1080/01635581.2013.770043] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
35 Su CH, Chen LJ, Liao JF, Cheng JT. Increase of phosphatase and tensin homolog by silymarin to inhibit human pharynx squamous cancer. J Med Food. 2013;16:778-784. [PMID: 23909904 DOI: 10.1089/jmf.2012.2534] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
36 Hu Y, Wang S, Wu X, Zhang J, Chen R, Chen M, Wang Y. Chinese herbal medicine-derived compounds for cancer therapy: a focus on hepatocellular carcinoma. J Ethnopharmacol. 2013;149:601-612. [PMID: 23916858 DOI: 10.1016/j.jep.2013.07.030] [Cited by in Crossref: 105] [Cited by in F6Publishing: 98] [Article Influence: 11.7] [Reference Citation Analysis]
37 Radko L, Cybulski W, Rzeski W. Cytoprotective effect of silybin against lasalocid-induced toxicity in HepG2 cells. Polish Journal of Veterinary Sciences 2013;16:275-82. [DOI: 10.2478/pjvs-2013-0038] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
38 Ting H, Deep G, Agarwal R. Molecular mechanisms of silibinin-mediated cancer chemoprevention with major emphasis on prostate cancer. AAPS J 2013;15:707-16. [PMID: 23588585 DOI: 10.1208/s12248-013-9486-2] [Cited by in Crossref: 51] [Cited by in F6Publishing: 43] [Article Influence: 5.7] [Reference Citation Analysis]
39 Kauntz H, Bousserouel S, Gossé F, Raul F. Epigenetic effects of the natural flavonolignan silibinin on colon adenocarcinoma cells and their derived metastatic cells. Oncol Lett 2013;5:1273-7. [PMID: 23599778 DOI: 10.3892/ol.2013.1190] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.2] [Reference Citation Analysis]
40 Radko L, Cybulski W, Rzeski W. The protective effect of silybin against lasalocid cytotoxic exposure on chicken and rat cell lines. Biomed Res Int 2013;2013:783519. [PMID: 23509777 DOI: 10.1155/2013/783519] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
41 Cao MR, Li Q, Liu ZL, Liu HH, Wang W, Liao XL, Pan YL, Jiang JW. Harmine induces apoptosis in HepG2 cells via mitochondrial signaling pathway. Hepatobiliary Pancreat Dis Int 2011;10:599-604. [PMID: 22146623 DOI: 10.1016/s1499-3872(11)60102-1] [Cited by in Crossref: 41] [Cited by in F6Publishing: 27] [Article Influence: 4.1] [Reference Citation Analysis]
42 Di Cesare Mannelli L, Zanardelli M, Failli P, Ghelardini C. Oxaliplatin-Induced Neuropathy: Oxidative Stress as Pathological Mechanism. Protective Effect of Silibinin. The Journal of Pain 2012;13:276-84. [DOI: 10.1016/j.jpain.2011.11.009] [Cited by in Crossref: 103] [Cited by in F6Publishing: 101] [Article Influence: 10.3] [Reference Citation Analysis]
43 Yu HC, Chen LJ, Cheng KC, Li YX, Yeh CH, Cheng JT. Silymarin inhibits cervical cancer cell through an increase of phosphatase and tensin homolog. Phytother Res. 2012;26:709-715. [PMID: 22016029 DOI: 10.1002/ptr.3618] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
44 Okano JI, Fujise Y, Abe R, Imamoto R, Murawaki Y. Chemoprevention against hepatocellular carcinoma. Clin J Gastroenterol 2011;4:185-97. [PMID: 26189518 DOI: 10.1007/s12328-011-0227-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
45 Loguercio C, Festi D. Silybin and the liver: From basic research to clinical practice. World J Gastroenterol 2011; 17(18): 2288-2301 [PMID: 21633595 DOI: 10.3748/wjg.v17.i18.2288] [Cited by in CrossRef: 215] [Cited by in F6Publishing: 187] [Article Influence: 19.5] [Reference Citation Analysis]
46 Lin Z, Chuang W. Influence of silibinin on differential expressions of total cytokine genes in human hepatocellular carcinoma cell lines. Biomedicine & Preventive Nutrition 2011;1:91-4. [DOI: 10.1016/j.bionut.2011.02.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
47 Li Y, Martin RC 2nd. Herbal medicine and hepatocellular carcinoma: applications and challenges. Evid Based Complement Alternat Med 2011;2011:541209. [PMID: 21799681 DOI: 10.1093/ecam/neq044] [Cited by in Crossref: 21] [Cited by in F6Publishing: 30] [Article Influence: 1.9] [Reference Citation Analysis]
48 Deep G, Agarwal R. Antimetastatic efficacy of silibinin: molecular mechanisms and therapeutic potential against cancer. Cancer Metastasis Rev 2010;29:447-63. [PMID: 20714788 DOI: 10.1007/s10555-010-9237-0] [Cited by in Crossref: 149] [Cited by in F6Publishing: 129] [Article Influence: 12.4] [Reference Citation Analysis]
49 Link A, Balaguer F, Goel A. Cancer chemoprevention by dietary polyphenols: promising role for epigenetics. Biochem Pharmacol. 2010;80:1771-1792. [PMID: 20599773 DOI: 10.1016/j.bcp.2010.06.036] [Cited by in Crossref: 309] [Cited by in F6Publishing: 253] [Article Influence: 25.8] [Reference Citation Analysis]
50 Xiangbing H, Yankai Z, Ming L, Yong L, Yu Z, Huiyong Z, Yingying C, Jing H, Yun X, Liang J, Rongyue C, Jingjing L. The fusion protein of HSP65 with tandem repeats of β-hCG acting as a potent tumor vaccine in suppressing hepatocarcinoma. International Immunopharmacology 2010;10:230-8. [DOI: 10.1016/j.intimp.2009.11.006] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
51 Brandon-Warner E, Sugg JA, Schrum LW, McKillop IH. Silibinin inhibits ethanol metabolism and ethanol-dependent cell proliferation in an in vitro model of hepatocellular carcinoma. Cancer Lett 2010;291:120-9. [PMID: 19900758 DOI: 10.1016/j.canlet.2009.10.004] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 2.8] [Reference Citation Analysis]
52 Hsu CY, Sun PL, Chang HC, Perng DS, Chen YS. Spontaneous regression of advanced hepatocellular carcinoma: a case report. Cases J. 2009;2:6251. [PMID: 19918565 DOI: 10.4076/1757-1626-2-6251] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 0.4] [Reference Citation Analysis]
53 Xu YH, Zhao LJ, Li Y. Alisol B acetate induces apoptosis of SGC7901 cells via mitochondrial and phosphatidylinositol 3-kinases/Akt signaling pathways. World J Gastroenterol 2009; 15(23): 2870-2877 [PMID: 19533808 DOI: 10.3748/wjg.15.2870] [Cited by in CrossRef: 27] [Cited by in F6Publishing: 26] [Article Influence: 2.1] [Reference Citation Analysis]
54 Cui W, Gu F, Hu KQ. Effects and mechanisms of silibinin on human hepatocellular carcinoma xenografts in nude mice. World J Gastroenterol 2009; 15(16): 1943-1950 [PMID: 19399925 DOI: 10.3748/wjg.15.1943] [Cited by in CrossRef: 45] [Cited by in F6Publishing: 40] [Article Influence: 3.5] [Reference Citation Analysis]
55 Ramakrishnan G, Lo Muzio L, Elinos-Báez CM, Jagan S, Augustine TA, Kamaraj S, Anandakumar P, Devaki T. Silymarin inhibited proliferation and induced apoptosis in hepatic cancer cells. Cell Prolif. 2009;42:229-240. [PMID: 19317806 DOI: 10.1111/j.1365-2184.2008.00581.x] [Cited by in Crossref: 47] [Cited by in F6Publishing: 46] [Article Influence: 3.6] [Reference Citation Analysis]
56 García-maceira P, Mateo J. Silibinin inhibits hypoxia-inducible factor-1α and mTOR/p70S6K/4E-BP1 signalling pathway in human cervical and hepatoma cancer cells: implications for anticancer therapy. Oncogene 2009;28:313-24. [DOI: 10.1038/onc.2008.398] [Cited by in Crossref: 111] [Cited by in F6Publishing: 112] [Article Influence: 7.9] [Reference Citation Analysis]
57 Momeny M, Khorramizadeh MR, Ghaffari SH, Yousefi M, Yekaninejad MS, Esmaeili R, Jahanshiri Z, Nooridaloii MR. Effects of silibinin on cell growth and invasive properties of a human hepatocellular carcinoma cell line, HepG-2, through inhibition of extracellular signal-regulated kinase 1/2 phosphorylation. European Journal of Pharmacology 2008;591:13-20. [DOI: 10.1016/j.ejphar.2008.06.011] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 2.9] [Reference Citation Analysis]
58 Winter HK, Ehrlich VA, Grusch M, Lackner A, Schulte-Hermann R, Grasl-Kraupp B, Mikulits W, Knasmüller S. Use of four new human-derived liver-cell lines for the detection of genotoxic compounds in the single-cell gel electrophoresis (SCGE) assay. Mutat Res 2008;657:133-9. [PMID: 18790080 DOI: 10.1016/j.mrgentox.2008.08.012] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
59 Ramasamy K, Agarwal R. Multitargeted therapy of cancer by silymarin. Cancer Lett. 2008;269:352-362. [PMID: 18472213 DOI: 10.1016/j.canlet.2008.03.053] [Cited by in Crossref: 229] [Cited by in F6Publishing: 193] [Article Influence: 16.4] [Reference Citation Analysis]